SBIR/STTR Research Award
IGF OT IGF DEVELOPMENT AND EVALUATION OF THE HEPAPLATE IPS A HIGH THROUGHPUT ORGAN ON A CHIP IPS HEPATOTOXICTY SCREENING PLATFORM
Award amount
$224,998Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MIMETAS US, INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- QGP7JLTGMAK9
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
This is an SBIR Phase I contract focused on improving the testing of hepatoxicity through the development of the organoplate
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies
- Development of the NephroPlate: A high-throughput kidney-on-a-chip platform for identifying chronic kidney disease therapies
- TOPIC #355 - SBIR PHASE II - A 3D PERFUSABLE PLATFORM FOR HTS ACROSS DIVERSE RACIAL/ETHNIC CANCER SPE
- A D PERFUSABLE PLATFORM FOR HTS ACROSS DIVERSE RACIAL ETHNIC CANCER SPECIMENS
Research funding history
5 SBIR/STTR records share this UEI (2016–2022). Reported award amounts total $4,752,885. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services